Abstract:Background: Coagulation factors, anticoagulants, and fibrinolytic proteins are important for hemostasis, and mutations affecting these proteins causes some rare inherited bleeding disorders that are particularly challenging to diagnose. Aims: This review provides current information on rare inherited bleeding disorders that are difficult to diagnose. Material & methods: A review of the literature was conducted for up to date information on rare and difficult to diagnose bleeding disorders. Results: Some rare bleeding disorders cause an inherited deficiency of multiple coagulation factors (F), such as combined FV and FVIII deficiency and familial vitamin K-dependent clotting factor deficiency. Additionally, congenital disorders of glycosylation can affect a variety of procoagulant and anticoagulant proteins and also platelets. Some bleeding disorders reflect mutations with unique impairments in the procoagulant/anticoagulant balance, including those caused by F5 mutations that secondarily increase the plasma levels of tissue factor pathway inhibitor as well as THBD mutations that increase functional thrombomodulin in plasma or cause a consumptive coagulopathy due to thrombomodulin deficiency. Some bleeding disorders accelerate fibrinolysis due to loss-of-function mutations in SERPINE1 and SERPINF2 or in the case of Quebec platelet disorder, a duplication mutation that rewires PLAU and selectively increases expression in megakaryocytes, resulting in a unique platelet-dependent gain-of-function defect in fibrinolysis. Discussion: Current information on rare and difficult to diagnose bleeding disorders indicates they have unique clinical and laboratory features, and pathogenic characteristics to consider for diagnostic evaluation. Conclusion: Laboratories and clinicians should consider rare inherited disorders, and difficult to diagnose conditions, in their strategy for diagnosing bleeding disorders.

Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia: case report

Case Report: Laboratory detection of a thrombotic tendency in a family with hypodysfibrinogenemia and a novel FGG mutation

Fibrin clot structure in patients with congenital dysfibrinogenaemia

Congenital Fibrinogen Disorders with Repeated Thrombosis

[A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain]

Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database

Clinical, Laboratory, and Molecular Aspects of Congenital Fibrinogen Disorders

Congenital (Hypo-)Dysfibrinogenemia and Bleeding: A Systematic Literature Review.

Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders

A novel γ-chain mutation p.Asp318His in a Chinese family with dysfibrinogenemia

The FGG c.952G>A variant causes congenital dysfibrinogenemia characterized by recurrent cerebral infarction: a case report

Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia.

Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys

A novel fibrinogen γ-chain frameshift mutation, p. Cys365Phefs*41, causing hypofibrinogenemia with bleeding phenotype in a Chinese family

Identification of a Novel Splicing Mutation in the Fibrinogen Gamma Chain Gene Leading to Dysfibrinogenaemia in a Chinese Pedigree.

Hyperfibrinolysis: a crucial phenotypic abnormality of posttraumatic fibrinolytic dysfunction

Paradoxical Bleeding and Thrombotic Episodes of Dysprothrombinaemia Due to a Homozygous Arg382His Mutation

Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders

Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: Experience from a haemophilia treatment centre

Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories

Severe haemorrhagic diathesis due to acquired hypofibrinogenemia in a patient with early T-cell precursor acute lymphoblastic leukaemia/lymphoma: a case report